INTEL CORP
INTCBusiness Summary
Intel Corporation is a global designer and manufacturer of semiconductor products, with its CPUs and other semiconductor solutions incorporated in computing and related end products and services utilized globally by consumers, enterprises, governments and educational organizations. The company operates as a U.S.-based integrated design manufacturer, or IDM, and is the only company undertaking research, design and development of leading-edge and next generation semiconductor manufacturing technologies and high-volume manufacturing of logic semiconductors utilizing leading-edge nodes in the U.S. The semiconductor industry in 2025 experienced momentum driven by significantly increased compute demand, particularly for GPU systems, driven by generative AI workloads; an expansion in the types of AI workloads; a PC market driven by user refreshes resulting from expanding AI capabilities, end-of-support for Windows 10 and aging devices from the COVID era; and increased demand for secure and geographically diversified supply chains in a period of increased geopolitical tensions.
Intel's primary competitors include AMD, which like Intel designs processors based on the x86 architecture, and companies that design processors based on the ARM architecture, such as Apple with its M series products, Qualcomm with its Snapdragon products and MediaTek with its Kompanio products. In the data center market, competitors include AMD, NVIDIA, and companies developing their own custom silicon, including many hyperscalers such as Amazon, Google, Meta and Microsoft. In the foundry business, Intel's primary competitor in leading-edge semiconductor process technology is TSMC, which holds a leading position in manufacturing at scale for the most advanced nodes, and Intel also competes directly with Samsung in this market. The company's three largest customers accounted for 43% 1 of net revenue in 2025, 45% 2 in 2024 and 40% 3 in 2023.
Intel generates revenue through the design, development, marketing, sale, support and servicing of CPUs and related semiconductor products, with substantially all of its revenue derived from product sales. The company's customers primarily include OEMs, ODMs, CSPs, and other manufacturers and service providers, and it markets and sells products through a combination of direct sales and indirect channels including distributors, resellers, retailers and OEM partners. The company's business is organized into three reportable segments: Client Computing Group (CCG), Data Center and AI (DCAI), and Intel Foundry, with an "all other" category that includes Mobileye, IMS Nanofabrication, and historical results from divested businesses including Altera.
The CCG segment delivers platforms and processors that power PCs and edge devices, with key product offerings including Intel Core and Intel Core Ultra client CPUs, discrete client GPUs under the Intel Arc brand, edge computing solutions, and connectivity products. CCG revenue was $32.228 billion 4 in 2025, $33.346 billion 5 in 2024, and $32.305 billion 6 in 2023, with operating income of $9.317 billion 7, $11.594 billion 8, and $10.128 billion 9 respectively. The DCAI segment delivers workload-optimized solutions based upon the x86 architecture for data centers, including CPUs, AI accelerators, NICs, IPUs, and custom ASICs, with key products including Intel Xeon server processors, discrete GPUs, and networking products. DCAI revenue was $16.919 billion 10 in 2025, $16.125 billion 11 in 2024, and $15.980 billion 12 in 2023, with operating income of $3.422 billion 13, $1.414 billion 14, and $945 million 15 respectively.
The Intel Foundry segment develops new leading-edge semiconductor process technologies and advanced packaging technologies and provides manufacturing, assembly and test and advanced packaging capacity and design enablement solutions. Intel Foundry revenue was $17.826 billion 16 in 2025, $17.317 billion 17 in 2024, and $18.504 billion 18 in 2023, with operating losses of $10.318 billion 19, $13.291 billion 20, and $7.083 billion 21 respectively. The "all other" category, which includes Mobileye, IMS, and Altera (through September 11, 2025), had revenue of $3.563 billion 22 in 2025, $3.601 billion 23 in 2024, and $5.463 billion 24 in 2023, with operating income (loss) of $264 million 25, $(57) million 26, and $1.507 billion 27 respectively.
In 2025, Intel completed several significant operational developments. On September 12, 2025, the company completed the divestiture of 51% of Altera for net purchase consideration of $4.3 billion 28, consisting of $4.8 billion 29 in cash proceeds, $500 million 30 in deferred cash proceeds, and offsets including $400 million 31 for cash transferred to Altera and approximately $469 million 32 in separation and employee-related costs. On August 27, 2025, Intel entered into a U.S. Government Agreement with the Department of Commerce, receiving $5.7 billion 33 in accelerated CHIPS Act disbursements and issuing 275 million 34 shares of common stock, a warrant to purchase up to 241 million 35 shares at $20.00 36 per share, and 159 million 37 Escrowed Shares. Intel also completed private placements with SoftBank Group for 87 million 38 shares at $23.00 39 per share for $2.0 billion 40 and with NVIDIA for 215 million 41 shares at $23.28 42 per share for $5.0 billion 43. The company initiated the 2025 Restructuring Plan, recognizing restructuring charges of $2.2 billion 44 in 2025, and reduced its core Intel workforce by approximately 15% 45 by the end of fiscal 2025 compared to Q2 2025 ending headcount.
For fiscal year 2025, Intel reported net revenue of $52.853 billion 46, compared to $53.101 billion 47 in 2024 and $54.228 billion 48 in 2023. Gross profit was $18.375 billion 49 in 2025, up from $17.345 billion 50 in 2024, with gross margin of 34.8% 51 versus 32.7% 52 in the prior year. Operating loss was $2.214 billion 53 in 2025, compared to an operating loss of $11.678 billion 54 in 2024. Net income attributable to Intel was a loss of $267 million 55 in 2025, compared to a loss of $18.756 billion 56 in 2024 and income of $1.689 billion 57 in 2023. Diluted loss per share attributable to Intel was $0.06 58 in 2025, compared to $4.38 59 in 2024 and earnings per share of $0.40 60 in 2023.
Business Outlook
The filing contains forward-looking statements regarding business plans and strategy, projections of future financial performance including future revenue, gross profits, capital expenditures and cash flows, but A primary growth vector is the revitalization of the x86 ecosystem, adapting and advancing x86 product offerings to support current and next-generation AI workloads. In 2025, Intel introduced its next generation client CPU code named Panther Lake, designed to combine improved power efficiency and performance to support next-generation AI-enabled workloads at the edge, and announced a strategic partnership with NVIDIA to co-develop custom client and data center products combining Intel's x86 CPU technologies with NVIDIA's AI and accelerated computing capabilities. The company expects Intel 18A, which first went into high-volume manufacturing in late 2025, to serve as the manufacturing process for multiple generations of future client and server CPU products, and is continuing development of Intel 14A, its next-generation node designed from inception as an offering to external customers.
Another major growth vector is the external foundry business, where Intel aims to leverage its U.S.-based capabilities in leading-edge semiconductor process technology R&D and manufacturing and advanced packaging to become a trusted foundry partner. Intel Foundry offerings include wafer fabrication, advanced packaging, chiplet integration and design enablement services. In 2025, Intel ramped Intel 18A into high-volume production and is seeking to establish it as the first significant node for government and enterprise foundry customers. The company is actively seeking customers for Intel 14A, but announced that if unable to secure a significant external foundry customer for Intel 14A, it may pause or discontinue its pursuit of next generation leading-edge process technologies, and in such event would expect over time to shift manufacturing to third-party foundries, particularly TSMC, as it develops products for nodes beyond Intel 18A and Intel 18A-P.
Intel is focused on margin and cost improvement through its enterprise-wide transformation. The 2025 Restructuring Plan is expected to result in total charges of approximately $2.2 billion 61, with a substantial majority of actions completed in Q4 2025 and the remainder expected to be completed in 2026. The company expects total R&D and MG&A expenses to decrease in 2026 relative to recent historical periods as a result of the 2025 and 2024 Restructuring Plans and other cost-reduction measures and the divestiture of Altera. In 2025, R&D expenses decreased by $2.8 billion 62, or 17% 63, from 2024, and MG&A expenses decreased by $883 million 64, or 16% 65, from 2024, primarily driven by lower payroll-related expenditures from headcount reductions.
Intel's operational outlook includes a more disciplined capital deployment strategy, better aligning new investments and key project milestones with market demand. In 2025, the company initiated the consolidation of its Costa Rican assembly and test operations into larger existing sites in Vietnam and Malaysia, expected to be completed by the end of 2026, slowed the pace of construction for its new Ohio wafer fabrication facility, and discontinued planned expansions in Germany (fab) and Poland (assembly and test facility). The company expects wafer fabrication supply constraints, primarily with respect to its Intel 7 and Intel 3 process nodes, to persist into 2026, with the most severe constraints impacting Q1 2026 66, limiting its ability to fully meet customer demand. As of December 27, 2025, Intel had 85,100 67 people, and its undesired turnover rate was 7.9% 68 in 2025.
Capital allocation priorities include continued investment in R&D and capital expenditures. R&D expenses were $13.8 billion 69 in 2025, $16.5 billion 70 in 2024, and $16.0 billion 71 in 2023. Net purchases of property, plant and equipment (net capital expenditures) were $11.204 billion 72 in 2025, $10.515 billion 73 in 2024, and $23.228 billion 74 in 2023. As of December 27, 2025, Intel had commitments for capital expenditures of $9.1 billion 75 for 2026 and $3.7 billion 76 in capital expenditures committed in the long term. The company has an ongoing authorization to repurchase shares, with $7.2 billion 77 remaining available as of December 27, 2025, though no shares were repurchased during fiscal year 2025. No dividends were paid in 2025, compared to $1.599 billion 78 in 2024 and $3.088 billion 79 in 2023.
A significant headwind is the potential pause or discontinuation of Intel 14A and successor leading-edge process technologies if the company is unable to secure a significant external foundry customer. The filing states that if this occurs, Intel would expect over time to shift manufacturing to third-party foundries, particularly TSMC, and would face risks including dependence on third-party foundries, losses with respect to investments in R&D and manufacturing facilities, loss of eligibility for government incentives, potential penalty payments under SCIP agreements, and loss of talent. The company had over $100 billion 80 of property, plant and equipment, net on its balance sheet as of December 27, 2025, the substantial majority of which relates to its foundry business.
Geopolitical tensions and trade policies present material constraints. Sales outside the U.S. accounted for 70% 81 of revenue for fiscal year 2025, with revenue from billings to China contributing 24% 82 of total revenue. The filing notes that geopolitical and trade tensions between the U.S. and China have led to increased tariffs and trade restrictions, and that the U.S. has imposed restrictions on the export of U.S.-regulated products and technology to certain Chinese technology companies. Additionally, the company faces risks from tensions and conflict affecting Israel and the Middle East, where it has a leading-edge fabrication facility and multiple product development centers, and from rising tensions between mainland China and Taiwan, where many of its products depend on suppliers for critical components.
Risk Factors
Intel faces intense competition across its product portfolio, having lost market share in recent years in both client and data center markets, and its data center business has been negatively impacted by the significant shift of customer spend toward GPUs optimized for AI workloads where Intel has been unsuccessful to date in becoming a meaningful participant. The company's external foundry strategy is highly risky and uncertain, with limited experience in the capital-intensive third-party foundry business and few external customers to date. If Intel is unable to secure a significant external foundry customer for Intel 14A, it may pause or discontinue its pursuit of next generation leading-edge process technologies, which would subject it to significant strategic, financial, and operational risks including dependence on third-party foundries like TSMC and potential material impairments on its over $100 billion 83 of property, plant and equipment. The company's significant debt obligations of $46.585 billion 84 in aggregate principal amount of senior unsecured notes and other borrowings, combined with a credit rating downgrade from BBB+ to BBB in August 2025, could affect future borrowing costs and access to capital markets. Geopolitical tensions, particularly between the U.S. and China where China contributed 24% 85 of total revenue, and conflicts affecting Israel where Intel has a leading-edge fabrication facility, present material risks to operations and financial results.
Management Priorities
Management's message emphasizes an enterprise-wide transformation to strengthen execution, enhance innovation, and better position Intel's products and offerings in a complex, highly competitive and rapidly evolving technology landscape. The strategy is centered on four core priorities: transforming the culture to become an engineering-focused, customer-centric organization; revitalizing the x86 ecosystem; growing the external foundry business; and expanding market opportunities by developing purpose-built ASICs and GPUs. Management states that if the company is unable to secure a significant external foundry customer for Intel 14A, it may pause or discontinue its pursuit of Intel 14A and successor leading-edge process technologies, and in such event would expect over time to shift manufacturing to third-party foundries, particularly TSMC. The filing notes that the company expects supply constraints to persist into 2026, with the most severe constraints impacting Q1 2026 86, limiting its ability to fully meet customer demand, and that total R&D and MG&A expenses are expected to decrease in 2026 relative to recent historical periods.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 7, MD&A — Operating Segment Results / Note 3: Operating Segments
- [2] Item 7, MD&A — Operating Segment Results / Note 3: Operating Segments
- [3] Item 7, MD&A — Operating Segment Results / Note 3: Operating Segments
- [4] Item 7, MD&A — Operating Segment Results
- [5] Item 7, MD&A — Operating Segment Results
- [6] Item 7, MD&A — Operating Segment Results
- [7] Item 7, MD&A — Operating Segment Results
- [8] Item 7, MD&A — Operating Segment Results
- [9] Item 7, MD&A — Operating Segment Results
- [10] Item 7, MD&A — Operating Segment Results
- [11] Item 7, MD&A — Operating Segment Results
- [12] Item 7, MD&A — Operating Segment Results
- [13] Item 7, MD&A — Operating Segment Results
- [14] Item 7, MD&A — Operating Segment Results
- [15] Item 7, MD&A — Operating Segment Results
- [16] Item 7, MD&A — Operating Segment Results
- [17] Item 7, MD&A — Operating Segment Results
- [18] Item 7, MD&A — Operating Segment Results
- [19] Item 7, MD&A — Operating Segment Results
- [20] Item 7, MD&A — Operating Segment Results
- [21] Item 7, MD&A — Operating Segment Results
- [22] Item 7, MD&A — Operating Segment Results
- [23] Item 7, MD&A — Operating Segment Results
- [24] Item 7, MD&A — Operating Segment Results
- [25] Item 7, MD&A — Operating Segment Results
- [26] Item 7, MD&A — Operating Segment Results
- [27] Item 7, MD&A — Operating Segment Results
- [28] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [29] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [30] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [31] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [32] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [33] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [34] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [35] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [36] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [37] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [38] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [39] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [40] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [41] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [42] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [43] Item 7, MD&A — Significant Events and Trends / Note 5: Earnings Per Share and Stockholders' Equity
- [44] Item 7, MD&A — Restructuring / Note 7: Restructuring and Other Charges
- [45] Item 7, MD&A — Restructuring
- [46] Item 7, MD&A — Consolidated Results of Operations
- [47] Item 7, MD&A — Consolidated Results of Operations
- [48] Item 7, MD&A — Consolidated Results of Operations
- [49] Item 7, MD&A — Consolidated Results of Operations
- [50] Item 7, MD&A — Consolidated Results of Operations
- [51] Item 7, MD&A — Consolidated Results of Operations
- [52] Item 7, MD&A — Consolidated Results of Operations
- [53] Item 7, MD&A — Consolidated Results of Operations
- [54] Item 7, MD&A — Consolidated Results of Operations
- [55] Item 7, MD&A — Consolidated Results of Operations
- [56] Item 7, MD&A — Consolidated Results of Operations
- [57] Item 7, MD&A — Consolidated Results of Operations
- [58] Item 7, MD&A — Consolidated Results of Operations
- [59] Item 7, MD&A — Consolidated Results of Operations
- [60] Item 7, MD&A — Consolidated Results of Operations
- [61] Item 7, MD&A — Restructuring / Note 7: Restructuring and Other Charges
- [62] Item 7, MD&A — Consolidated Results of Operations
- [63] Item 7, MD&A — Consolidated Results of Operations
- [64] Item 7, MD&A — Consolidated Results of Operations
- [65] Item 7, MD&A — Consolidated Results of Operations
- [66] Item 7, MD&A — Operating Segment Results
- [67] Item 1, Business — People
- [68] Item 1, Business — People
- [69] Item 7, MD&A — Consolidated Results of Operations
- [70] Item 7, MD&A — Consolidated Results of Operations
- [71] Item 7, MD&A — Consolidated Results of Operations
- [72] Item 7, MD&A — Liquidity and Capital Resources
- [73] Item 7, MD&A — Liquidity and Capital Resources
- [74] Item 7, MD&A — Liquidity and Capital Resources
- [75] Item 7, MD&A — Liquidity and Capital Resources
- [76] Item 7, MD&A — Liquidity and Capital Resources
- [77] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
- [78] Item 7, MD&A — Liquidity and Capital Resources / Note 5: Earnings Per Share and Stockholders' Equity
- [79] Item 7, MD&A — Liquidity and Capital Resources / Note 5: Earnings Per Share and Stockholders' Equity
- [80] Item 1A, Risk Factors
- [81] Item 1A, Risk Factors
- [82] Item 1A, Risk Factors
- [83] Item 1A, Risk Factors
- [84] Item 7, MD&A — Liquidity and Capital Resources / Note 13: Borrowings
- [85] Item 1A, Risk Factors
- [86] Item 7, MD&A — Operating Segment Results
- [87] Item 8, Consolidated Statements of Operations
- [88] Item 8, Consolidated Statements of Operations
- [89] Item 8, Consolidated Statements of Operations
- [90] Item 8, Consolidated Statements of Operations
- [91] Item 8, Consolidated Statements of Operations
- [92] Item 8, Consolidated Statements of Operations
- [93] Item 8, Consolidated Statements of Operations
- [94] Item 8, Consolidated Statements of Operations
- [95] Item 8, Consolidated Statements of Operations
- [96] Item 8, Consolidated Statements of Operations
- [97] Item 8, Consolidated Statements of Operations
- [98] Item 7, MD&A — Consolidated Results of Operations
- [99] Item 7, MD&A — Consolidated Results of Operations
- [100] Item 8, Consolidated Statements of Operations
- [101] Item 8, Consolidated Statements of Operations
- [102] Item 8, Consolidated Statements of Cash Flows
- [103] Item 8, Consolidated Statements of Cash Flows
- [104] Item 7, MD&A — Liquidity and Capital Resources
- [105] Item 7, MD&A — Liquidity and Capital Resources
- [106] Item 7, MD&A — Liquidity and Capital Resources
- [107] Item 7, MD&A — Liquidity and Capital Resources
- [108] Item 7, MD&A — Liquidity and Capital Resources
- [109] Item 7, MD&A — Liquidity and Capital Resources
- [110] Item 7, MD&A — Significant Events and Trends / Note 10: Acquisitions and Divestitures
- [111] Item 7, MD&A — Consolidated Results of Operations / Note 5: Earnings Per Share and Stockholders' Equity
- [112] Item 7, MD&A — Restructuring / Note 7: Restructuring and Other Charges
- [113] Item 7, MD&A — Restructuring / Note 6: Other Financial Statement Details
- [114] Item 7, MD&A — Restructuring / Note 11: Goodwill
- [115] Item 7, MD&A — Consolidated Results of Operations / Note 8: Income Taxes
- [116] Item 7, MD&A — Operating Segment Results
- [117] Item 7, MD&A — Operating Segment Results
- [118] Item 7, MD&A — Operating Segment Results
- [119] Item 7, MD&A — Operating Segment Results
- [120] Item 7, MD&A — Operating Segment Results
- [121] Item 7, MD&A — Operating Segment Results
Analysis on 6/8/2026